A Study of ZN-c3 in Participants With Solid Tumors
Conditions: Solid Tumor; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Triple Negative Breast Cancer; Small Cell Lung Cancer; Metastatic Breast Cancer; Malignant Melanoma; Non Small Cell Lung Cancer; Urothelial Carcinoma Interventions: Drug: ZN-c3; Drug: Talazoparib; Drug: Pembrolizumab Sponsors: K-Group Beta; IQVIA Biotech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer | Cancer & Oncology | Carcinoma | Melanoma | Research | Skin Cancer | Study